Axcynsis Therapeutics
Axcynsis Therapeutics

Axcynsis Therapeutics Information

Contact top employees from Axcynsis Therapeutics

Summary

Axcynsis Therapeutics is at the forefront of developing cutting-edge Antibody Drug Conjugate (ADC) therapies. Our team's profound expertise, pioneering and proprietary ADC technology platform, endurin...Show more

Industries

Biotechnology

Headquarters Location

Employees Size

10-50 employees

Specialties

Antibody, Bioconjugation, ADC , Chemistry, Drug Development

Founded

2022

Contact Axcynsis Therapeutics

Organization Website

Employees Turnover 2 quarter 2025

Length of Employment
arrow
Employee tenure at Axcynsis Therapeutics shows a diverse range of experience levels:
25% have been with the company for less than 1 year50% for 1–2 years25% for 3–4 years
Ex-employees positions
In Company
In New Company
Contact top employees from Axcynsis Therapeutics
ZOU BIN
Founder and CEO
View
Bryan KS Yeung
Vice President Chemistry
View
Yun Xuan Wong
Senior Operations Manager
View
Alex Ling
Antibody Scientist
View
Yinwen Cheng
Scientist (biology)
View
Xiyun Zhang
Associate Researcher
View
Chen Zhong
SVP Biology/Antibody
View
BACK TO TOP